An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma

Introduction: Fibrosis, a primary cause of hepatocellular carcinoma (HCC), is intimately associated with inflammation, the tumor microenvironment (TME), and multiple carcinogenic pathways. Currently, due to widespread inter- and intra-tumoral heterogeneity of HCC, the efficacy of immunotherapy is li...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Long, Liu, Zaoqu, Meng, Lingfang, Li, Lifeng, Gao, Jie, Yu, Shizhe, Hu, Bowen, Yang, Han, Guo, Wenzhi, Zhang, Shuijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712696/
https://www.ncbi.nlm.nih.gov/pubmed/34970594
http://dx.doi.org/10.3389/fmolb.2021.766609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712696/
https://www.ncbi.nlm.nih.gov/pubmed/34970594
http://dx.doi.org/10.3389/fmolb.2021.766609

Ejemplares similares